ScoreComparison
Why is Tonix Pharmaceuticals Holding Corp. ?
1
With a growth in Net Sales of 96.92%, the company declared Very Positive results in Jun 26
- NET PROFIT(HY) Higher at USD -80.75 MM
- NET SALES(Q) Highest at USD 13.54 MM
- OPERATING PROFIT MARGIN(Q) Highest at -309.48 %
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -59.51%, its profits have fallen by -57.9%
3
High Institutional Holdings at 57.62%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 16.46% over the previous quarter.
4
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 15.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -59.51% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Tonix Pharmaceuticals Holding Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Tonix Pharmaceuticals Holding Corp. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Tonix Pharmaceuticals Holding Corp.
-59.51%
-1.35
70.46%
S&P 500
15.76%
1.20
13.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
69.79%
EBIT Growth (5y)
-186.65%
EBIT to Interest (avg)
-91.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
0.09
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
41.16%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.70
EV to EBIT
0.28
EV to EBITDA
0.28
EV to Capital Employed
-0.93
EV to Sales
-2.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-49.74%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend26What is working for the Company
NET PROFIT(HY)
Higher at USD -80.75 MM
NET SALES(Q)
Highest at USD 13.54 MM
OPERATING PROFIT MARGIN(Q)
Highest at -309.48 %
RAW MATERIAL COST(Y)
Fallen by -200.34% (YoY
CASH AND EQV(HY)
Highest at USD 361.7 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.28 times
EPS(Q)
Highest at USD -2.44
-10What is not working for the Company
NET PROFIT(HY)
At USD -80.75 MM has Grown at -87.74%
OPERATING CASH FLOW(Y)
Lowest at USD -155.19 MM
Here's what is working for Tonix Pharmaceuticals Holding Corp.
Net Sales
At USD 13.54 MM has Grown at 208.59%
over average net sales of the previous four periods of USD 4.39 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Net Sales
Highest at USD 13.54 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Profit Margin
Highest at -309.48 % and Grown
In each period in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
Higher at USD -80.75 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
EPS
Highest at USD -2.44
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 361.7 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 1.28 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -200.34% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Tonix Pharmaceuticals Holding Corp.
Net Profit
At USD -80.75 MM has Grown at -87.74%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -155.19 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Footer loading
